Dubai, 18th June 2014. Invivoscribe Technologies, Inc. (San Diego, CA, USA) signed an exclusive master distribution agreement with the Alliance Global Group (Dubai, UAE) to bring Invivoscribe Technologies personalized molecular diagnosticsto AGBL’s markets. “Modern advancement in personalized medicine relies on determining a patients’ genetic makeup, which plays a critical role